SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on June 15, 2011. The report serves as a current disclosure regarding a scheduled investor presentation. Note: The input metadata references "Dominari Holdings Inc.," but the filing text explicitly identifies the registrant as Spherix Incorporated.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This document is a procedural notice regarding a regulatory disclosure event rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces a future event.
Guidance, Outlook, and Management Commentary
On June 16, 2011, at 2:00 p.m. Eastern time, Dr. Claire Kruger, Chief Executive Officer, is scheduled to present to investors at the 5th Lippert/Heilshorn & Associates Life Sciences and Medical Technologies Virtual Conference. The presentation is attached as Exhibit 99.1 and is available on the company's website.
Investor Verification Checklist
- Verify the correct registrant name is Spherix Incorporated, not Dominari Holdings Inc.
- Access the attached Exhibit 99.1 or the company website (www.spherix.com) for the actual financial overview and management commentary.
- Confirm the date and time of the investor presentation (June 16, 2011, 2:00 p.m. ET).